Suchergebnisse - "Hochhaus, A."

PubPharm (35)

1

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

enthalten in: Leukemia | 2016

von Steegmann, J. | Baccarani, M. | Breccia, M. | +15

CommentIn: Leukemia. 2017 Mar;31(3):771-772. - PMID 27909345

2

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase : results from the European ENEST1st study

enthalten in: Leukemia | 2016

von Hochhaus, A. | Rosti, G. | Cross, N. | +22

3

Response to Ho-Wan Ip and Chi-Chiu

enthalten in: Leukemia | 2015

von Cross, N. | Müller, M. | Hochhaus, A.

CommentOn: Leukemia. 2015 May;29(5):999-1003. - PMID 25652737

4

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

enthalten in: Leukemia | 2015

von Cross, N. | White, H. | Colomer, D. | +18

CommentIn: Leukemia. 2015 Jul;29(7):1620-1. - PMID 25907600

5

Chronic myelogenous leukemia

enthalten in: Der Internist | 2015

von Hochhaus, A. | La Rosée, P. | Eigendorff, E. | +1

6

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase

enthalten in: Leukemia | 2013

von Metzgeroth, G. | Schwaab, J. | Gosenca, D. | +6

7

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia

enthalten in: Leukemia | 2013

von Ottmann, O. | Larson, R. | Kantarjian, H. | +7

8

Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors

enthalten in: American journal of hematology | 2013

von Cortes, J. | Digumarti, R. | Parikh, P. | +8

9

Standardized definitions of molecular response in chronic myeloid leukemia

enthalten in: Leukemia | 2012

von Cross, N. | White, H. | Müller, M. | +2

10

Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance : 24-month follow-up results

enthalten in: Leukemia | 2012

von le Coutre, P. | Giles, F. | Hochhaus, A. | +8